Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
European Journal of Pediatrics
Erschienen in: European Journal of Pediatrics 4/2020

04.02.2020 | Review

Diagnosis and management of iron deficiency in children with or without anemia: consensus recommendations of the SPOG Pediatric Hematology Working Group

verfasst von: Veneranda Mattiello, Markus Schmugge, Heinz Hengartner, Nicolas von der Weid, Raffaele Renella, on behalf of the SPOG Pediatric Hematology Working Group

Erschienen in: European Journal of Pediatrics | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Iron deficiency is the most prevalent nutritional deficiency affecting children and adolescents worldwide. A consistent body of epidemiological data demonstrates an increased incidence of iron deficiency at three timepoints: in the neonatal period, in preschool children, and in adolescents, where it particularly affects females.
Conclusion: This narrative review focuses on the most suggestive symptoms of iron deficiency in childhood, describes the diagnostic procedures in situations with or without anemia, and provides Swiss expert-based management recommendations for the pediatric context.
What is Known:
• Iron deficiency (ID) is one of the most common challenges faced by pediatricians.
• Significant progress in the diagnosis and therapy of ID has been made over the last decade.
What is New:
• Our expert panel provides ID management recommendations based on the best available evidence.
• They include strategies for ID diagnosis and therapy, both oral and intravenous.
Literatur
1.
WHO (2016) Guideline: daily iron supplementation in infants and children. In: Committee GR (ed) World Health Organization (WHO). Switzerland, Geneva
2.
Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, Lux S (2015) Nathan and Oski’s hematology of infancy and childhood, 8th edn. Saunders, Philadelphia
3.
Domellof M, Braegger C, Campoy C, Colomb V, Decsi T, Fewtrell M, Hojsak I, Mihatsch W, Molgaard C, Shamir R, Turck D, van Goudoever J, Nutrition ECo (2014) Iron requirements of infants and toddlers. J Pediatr Gastroenterol Nutr 58:119–129PubMed
4.
Sekhar DL, Murray-Kolb LE, Kunselman AR, Weisman CS, Paul IM (2017) Association between menarche and iron deficiency in non-anemic young women. PLoS One 12:e0177183PubMedPubMedCentral
5.
Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L (2016) Iron deficiency anaemia. Lancet 387:907–916PubMed
6.
Global Burden of Disease Pediatrics C, Kyu HH, Pinho C, Wagner JA, Brown JC, Bertozzi-Villa A, Charlson FJ et al (2016) Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the global burden of disease 2013 study. JAMA Pediatr 170:267–287
7.
Auerbach M, Adamson JW (2016) How we diagnose and treat iron deficiency anemia. Am J Hematol 91:31–38PubMed
8.
Camaschella C (2017) New insights into iron deficiency and iron deficiency anemia. Blood Rev 31:225–233PubMed
9.
Beard J (2003) Iron deficiency alters brain development and functioning. J Nutr 133:1468S–1472SPubMed
10.
Lukowski AF, Koss M, Burden MJ, Jonides J, Nelson CA, Kaciroti N, Jimenez E, Lozoff B (2010) Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory. Nutr Neurosci 13:54–70PubMedPubMedCentral
11.
Musallam KM, Taher AT (2018) Iron deficiency beyond erythropoiesis: should we be concerned? Curr Med Res Opin 34:81–93PubMed
12.
Vallee L (2017) Iron and neurodevelopment. Arch Pediatr 24:5S18–15S22PubMed
13.
Sachdev H, Gera T, Nestel P (2005) Effect of iron supplementation on mental and motor development in children: systematic review of randomised controlled trials. Public Health Nutr 8:117–132PubMed
14.
Pratt JJ, Khan KS (2016) Non-anaemic iron deficiency - a disease looking for recognition of diagnosis: a systematic review. Eur J Haematol 96:618–628PubMed
15.
Szajewska H, Ruszczynski M, Chmielewska A (2010) Effects of iron supplementation in nonanemic pregnant women, infants, and young children on the mental performance and psychomotor development of children: a systematic review of randomized controlled trials. Am J Clin Nutr 91:1684–1690PubMed
16.
Angulo-Barroso RM, Li M, Santos DC, Bian Y, Sturza J, Jiang Y, Kaciroti N, Richards B, Lozoff B (2016) Iron supplementation in pregnancy or infancy and motor development: a randomized controlled trial. Pediatrics 137:e20153547PubMedPubMedCentral
17.
Friel JK, Aziz K, Andrews WL, Harding SV, Courage ML, Adams RJ (2003) A double-masked, randomized control trial of iron supplementation in early infancy in healthy term breast-fed infants. J Pediatr 143:582–586PubMed
18.
Lind T, Lonnerdal B, Stenlund H, Gamayanti IL, Ismail D, Seswandhana R, Persson LA (2004) A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: effects on growth and development. Am J Clin Nutr 80:729–736PubMed
19.
Moffatt ME, Longstaffe S, Besant J, Dureski C (1994) Prevention of iron deficiency and psychomotor decline in high-risk infants through use of iron-fortified infant formula: a randomized clinical trial. J Pediatr 125:527–534PubMed
20.
Olney DK, Pollitt E, Kariger PK, Khalfan SS, Ali NS, Tielsch JM, Sazawal S, Black R, Allen LH, Stoltzfus RJ (2006) Combined iron and folic acid supplementation with or without zinc reduces time to walking unassisted among Zanzibari infants 5- to 11-mo old. J Nutr 136:2427–2434PubMed
21.
Oski FA, Honig AS (1978) The effects of therapy on the developmental scores of iron-deficient infants. J Pediatr 92:21–25PubMed
22.
Stoltzfus RJ, Kvalsvig JD, Chwaya HM, Montresor A, Albonico M, Tielsch JM, Savioli L, Pollitt E (2001) Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study. BMJ 323:1389–1393PubMedPubMedCentral
23.
Falkingham M, Abdelhamid A, Curtis P, Fairweather-Tait S, Dye L, Hooper L (2010) The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis. Nutr J 9:4PubMedPubMedCentral
24.
Mattiello V, Sizonenko S, Baleydier F, Bernard F, Diezi M, Renella R (2019) Iron deficiency with and without anemia in children: a brief update for caregivers. Rev Med Suisse 15:376–381PubMed
25.
Cook RL, O'Dwyer NJ, Parker HM, Donges CE, Cheng HL, Steinbeck KS, Cox EP, Franklin JL, Garg ML, Rooney KB, O'Connor HT (2017) Iron deficiency anemia, not iron deficiency, is associated with reduced attention in healthy young women. Nutrients 9:E1216PubMed
26.
Halterman JS, Kaczorowski JM, Aligne CA, Auinger P, Szilagyi PG (2001) Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 107:1381–1386PubMed
27.
Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J (1996) Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 348:992–996PubMed
28.
Felt BT, Biermann B, Christner JG, Kochhar P, Harrison RV (2014) Diagnosis and management of ADHD in children. Am Fam Physician 90:456–464PubMed
29.
Konofal E, Lecendreux M, Deron J, Marchand M, Cortese S, Zaim M, Mouren MC, Arnulf I (2008) Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 38:20–26PubMed
30.
Calarge C, Farmer C, DiSilvestro R, Arnold LE (2010) Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 20:495–502PubMedPubMedCentral
31.
Cortese S, Konofal E, Bernardina BD, Mouren MC, Lecendreux M (2009) Sleep disturbances and serum ferritin levels in children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry 18:393–399PubMed
32.
Demirci K, Yildirim Bas F, Arslan B, Salman Z, Akpinar A, Demirdas A (2017) The investigation of symptoms and diagnoses of adult-attention deficit/hyperactivity disorder in women with iron deficiency anemia. Noro Psikiyatr Ars 54:72–77PubMed
33.
Islam K, Seth S, Saha S, Roy A, Das R, Datta AK (2018) A study on association of iron deficiency with attention deficit hyperactivity disorder in a tertiary care center. Indian J Psychiatry 60:131–134PubMedPubMedCentral
34.
Juneja M, Jain R, Singh V, Mallika V (2010) Iron deficiency in Indian children with attention deficit hyperactivity disorder. Indian Pediatr 47:955–958PubMed
35.
Konofal E, Lecendreux M, Arnulf I, Mouren MC (2004) Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 158:1113–1115PubMed
36.
Turner CA, Xie D, Zimmerman BM, Calarge CA (2012) Iron status in toddlerhood predicts sensitivity to psychostimulants in children. J Atten Disord 16:295–303PubMed
37.
Romanos M, Tiesler CM, Koletzko S, Berdel D, von Berg A, Hoffmann B, Schaaf B, Herbarth O, Lehmann I, Bauer CP, Stach B, Gerlach M, Schulte-Korne G, Heinrich J (2013) No cross-sectional and longitudinal association of ferritin and symptoms of attention-deficit-/hyperactivity disorder in a large population-based sample of children: results from the GINIplus and LISAplus studies. Atten Defic Hyperact Disord 5:313–320PubMed
38.
Wang Y, Huang L, Zhang L, Qu Y, Mu D (2017) Iron status in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. PLoS One 12:e0169145PubMedPubMedCentral
39.
Sever Y, Ashkenazi A, Tyano S, Weizman A (1997) Iron treatment in children with attention deficit hyperactivity disorder. A preliminary report. Neuropsychobiology 35:178–180PubMed
40.
Tseng PT, Cheng YS, Yen CF, Chen YW, Stubbs B, Whiteley P, Carvalho AF, Li DJ, Chen TY, Yang WC, Tang CH, Chu CS, Yang WC, Liang HY, Wu CK, Lin PY (2018) Peripheral iron levels in children with attention-deficit hyperactivity disorder: a systematic review and meta-analysis. Sci Rep 8:788PubMedPubMedCentral
41.
El-Baz FM, Youssef AM, Khairy E, Ramadan D, Youssef WY (2019) Association between circulating zinc/ferritin levels and parent Conner’s scores in children with attention deficit hyperactivity disorder. Eur Psychiatry 62:68–73PubMed
42.
Picchietti D, Allen RP, Walters AS, Davidson JE, Myers A, Ferini-Strambi L (2007) Restless legs syndrome: prevalence and impact in children and adolescents--the Peds REST study. Pediatrics 120:253–266PubMed
43.
Yilmaz K, Kilincaslan A, Aydin N, Kor D (2011) Prevalence and correlates of restless legs syndrome in adolescents. Dev Med Child Neurol 53:40–47PubMed
44.
Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study G (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med 15:860–873PubMed
45.
Earley CJ, Connor J, Garcia-Borreguero D, Jenner P, Winkelman J, Zee PC, Allen R (2014) Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease). Sleep Med 15:1288–1301PubMed
46.
Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, Palsson S, Sigmundsson T, Sigurdsson AP, Eiriksdottir I, Soebech E, Bliwise D, Beck JM, Rosen A, Waddy S, Trotti LM, Iranzo A, Thambisetty M, Hardarson GA, Kristjansson K, Gudmundsson LJ, Thorsteinsdottir U, Kong A, Gulcher JR, Gudbjartsson D, Stefansson K (2007) A genetic risk factor for periodic limb movements in sleep. N Engl J Med 357:639–647PubMed
47.
Catoire H, Dion PA, Xiong L, Amari M, Gaudet R, Girard SL, Noreau A, Gaspar C, Turecki G, Montplaisir JY, Parker JA, Rouleau GA (2011) Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis. Ann Neurol 70:170–175PubMed
48.
Allen RP, Picchietti DL, Auerbach M, Cho YW, Connor JR, Earley CJ, Garcia-Borreguero D, Kotagal S, Manconi M, Ondo W, Ulfberg J, Winkelman JW, International Restless Legs Syndrome Study G (2018) Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med 41:27–44PubMed
49.
Leung AKC, Leung AAM, Wong AHC, Hon KL (2019) Breath-holding spells in pediatrics: a narrative review of the current evidence. Curr Pediatr Rev 15:22–29PubMedPubMedCentral
50.
Jain R, Omanakuttan D, Singh A, Jajoo M (2017) Effect of iron supplementation in children with breath holding spells. J Paediatr Child Health 53:749–753PubMed
51.
Kolkiran A, Tutar E, Atalay S, Deda G, Cin S (2005) Autonomic nervous system functions in children with breath-holding spells and effects of iron deficiency. Acta Paediatr 94:1227–1231PubMed
52.
Zehetner A (2011) Iron supplementation reduces the frequency and severity of breath-holding attacks in non-anaemic children. Clin Pract 1:e98PubMedPubMedCentral
53.
54.
Borgna-Pignatti C, Zanella S (2016) Pica as a manifestation of iron deficiency. Expert Rev Hematol 9:1075–1080PubMed
55.
Yadav D, Chandra J (2011) Iron deficiency: beyond anemia. Indian J Pediatr 78:65–72PubMed
56.
Brown WD, Dyment PG (1972) Pagophagia and iron deficiency anemia in adolescent girls. Pediatrics 49:766–767PubMed
57.
Hinton PS, Sinclair LM (2007) Iron supplementation maintains ventilatory threshold and improves energetic efficiency in iron-deficient nonanemic athletes. Eur J Clin Nutr 61:30–39PubMed
58.
Hinton PS (2014) Iron and the endurance athlete. Appl Physiol Nutr Metab 39:1012–1018PubMed
59.
Peeling P, Dawson B, Goodman C, Landers G, Wiegerinck ET, Swinkels DW, Trinder D (2009) Training surface and intensity: inflammation, hemolysis, and hepcidin expression. Med Sci Sports Exerc 41:1138–1145PubMed
60.
Roecker L, Meier-Buttermilch R, Brechtel L, Nemeth E, Ganz T (2005) Iron-regulatory protein hepcidin is increased in female athletes after a marathon. Eur J Appl Physiol 95:569–571PubMed
61.
Sinclair LM, Hinton PS (2005) Prevalence of iron deficiency with and without anemia in recreationally active men and women. J Am Diet Assoc 105:975–978PubMed
62.
DellaValle DM, Haas JD (2011) Impact of iron depletion without anemia on performance in trained endurance athletes at the beginning of a training season: a study of female collegiate rowers. Int J Sport Nutr Exerc Metab 21:501–506PubMed
63.
Sharma R, Stanek JR, Koch TL, Grooms L, O'Brien SH (2016) Intravenous iron therapy in non-anemic iron-deficient menstruating adolescent females with fatigue. Am J Hematol 91:973–977PubMed
64.
Rowland TW, Deisroth MB, Green GM, Kelleher JF (1988) The effect of iron therapy on the exercise capacity of nonanemic iron-deficient adolescent runners. Am J Dis Child 142:165–169PubMed
65.
Brutsaert TD, Hernandez-Cordero S, Rivera J, Viola T, Hughes G, Haas JD (2003) Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr 77:441–448PubMed
66.
Brownlie T, Utermohlen V, Hinton PS, Haas JD (2004) Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 79:437–443PubMed
67.
Gera T, Sachdev HP (2002) Effect of iron supplementation on incidence of infectious illness in children: systematic review. BMJ 325:1142PubMedPubMedCentral
68.
Murray MJ, Murray AB, Murray MB, Murray CJ (1978) The adverse effect of iron repletion on the course of certain infections. Br Med J 2:1113–1115PubMedPubMedCentral
69.
Tansarli GS, Karageorgopoulos DE, Kapaskelis A, Gkegkes I, Falagas ME (2013) Iron deficiency and susceptibility to infections: evaluation of the clinical evidence. Eur J Clin Microbiol Infect Dis 32:1253–1258PubMed
70.
Zimmermann MB, Hurrell RF (2007) Nutritional iron deficiency. Lancet 370:511–520PubMed
71.
Long H, Yi JM, Hu PL, Li ZB, Qiu WY, Wang F, Zhu S (2012) Benefits of iron supplementation for low birth weight infants: a systematic review. BMC Pediatr 12:99PubMedPubMedCentral
72.
Huang SC, Yang YJ, Cheng CN, Chen JS, Lin CH (2010) The etiology and treatment outcome of iron deficiency and iron deficiency anemia in children. J Pediatr Hematol Oncol 32:282–285PubMed
73.
Camaschella C (2015) Iron-deficiency anemia. N Engl J Med 372:1832–1843PubMed
74.
75.
Hershko C, Camaschella C (2014) How I treat unexplained refractory iron deficiency anemia. Blood 123:326–333PubMed
76.
Polin V, Coriat R, Perkins G, Dhooge M, Abitbol V, Leblanc S, Prat F, Chaussade S (2013) Iron deficiency: from diagnosis to treatment. Dig Liver Dis 45:803–809PubMed
77.
Hudson BH, Hale AT, Irving RP, Li S, York JD (2018) Modulation of intestinal sulfur assimilation metabolism regulates iron homeostasis. Proc Natl Acad Sci U S A 115:3000–3005PubMedPubMedCentral
78.
Ginzburg YZ (2019) New diagnostic tools for delineating iron status. Hematol Am Soc Hematol Educ Program 2019:327–336
79.
Baker RD, Greer FR, Committee on Nutrition American Academy of P (2010) Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics 126:1040–1050PubMed
80.
Committee UNS (2012) Screening for iron deficiency anaemia in children under 5 years of age. Version 2
81.
Siu AL, Force USPST (2015) Screening for iron deficiency anemia in young children: USPSTF recommendation statement. Pediatrics 136:746–752PubMed
82.
de Montalembert M, Bresson JL, Brouzes C, Ruemmele FM, Puy H, Beaumont C (2012) Diagnosis of hypochromic microcytic anemia in children. Arch Pediatr 19:295–304PubMed
83.
Peyrin-Biroulet L, Williet N, Cacoub P (2015) Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr 102:1585–1594PubMed
84.
Rubeor A, Goojha C, Manning J, White J (2018) Does iron supplementation improve performance in iron-deficient nonanemic athletes? Sports Health 10:400–405PubMedPubMedCentral
85.
(2016) Guideline: daily iron supplementation in infants and children, Geneva
86.
Jonker FA, Boele van Hensbroek M, Leenstra T, Vet RJ, Brabin BJ, Maseko N, Gushu MB, Emana M, Kraaijenhagen R, Tjalsma H, Swinkels DW, Calis JC (2014) Conventional and novel peripheral blood iron markers compared against bone marrow in Malawian children. J Clin Pathol 67:717–723PubMed
87.
Abdullah K, Birken CS, Maguire JL, Fehlings D, Hanley AJ, Thorpe KE, Parkin PC (2017) Re-evaluation of serum ferritin cut-off values for the diagnosis of iron deficiency in children aged 12-36 months. J Pediatr 188:287–290PubMed
88.
Larsson SM, Hillarp A, Hellstrom-Westas L, Domellof M, Lundahl T, Andersson O (2019) When age really matters; ferritin reference intervals during infancy revisited. Scand J Clin Lab Invest 79:590–594PubMed
89.
Daru J, Colman K, Stanworth SJ, De La Salle B, Wood EM, Pasricha SR (2017) Serum ferritin as an indicator of iron status: what do we need to know? Am J Clin Nutr 106:1634S–1639SPubMedPubMedCentral
90.
Quadri A, Gojanovic B, Noack P, Brunner S, Huber A, Kriemler S (2018) Esenmangel bei Sportlern – Neue Empfehlungen zur Abklärung und Therapie. Swiss Sports Exerc Med 66:26–29
91.
Bohn MK, Higgins V, Asgari S, Leung F, Hoffman B, Macri J, Adeli K (2019) Paediatric reference intervals for 17 Roche cobas 8000 e602 immunoassays in the CALIPER cohort of healthy children and adolescents. Clin Chem Lab Med 57:1968–1979PubMed
92.
Stuart H, Orkin DGN, David Ginsburg A, Look T, Fisher DE, Lux S (2015) Nathan and Oski’s hematology of infancy and childhood, 8th edn. Saunders, Philadelphia
93.
Vazquez-Lopez MA, Lopez-Ruzafa E, Ibanez-Alcalde M, Martin-Gonzalez M, Bonillo-Perales A, Lendinez-Molinos F (2019) The usefulness of reticulocyte haemoglobin content, serum transferrin receptor and the sTfR-ferritin index to identify iron deficiency in healthy children aged 1-16 years. Eur J Pediatr 178:41–49PubMed
94.
Waldvogel Abramowski S, Favrat B, Vaucher P, Cornuz J, Tissot JD (2013) Diagnostic markers of iron deficiency: which should we choose? Rev Med Suisse 9:380–383PubMed
95.
Thuret I (2017) Biological diagnosis of iron deficiency in children. Arch Pediatr 24:5S6–5S13PubMed
96.
Hershko C, Skikne B (2009) Pathogenesis and management of iron deficiency anemia: emerging role of celiac disease, Helicobacter pylori, and autoimmune gastritis. Semin Hematol 46:339–350PubMed
97.
Cooke AG, McCavit TL, Buchanan GR, Powers JM (2017) Iron deficiency anemia in adolescents who present with heavy menstrual bleeding. J Pediatr Adolesc Gynecol 30:247–250PubMed
98.
Tunnessen WW Jr, Oski FA (1987) Consequences of starting whole cow milk at 6 months of age. J Pediatr 111:813–816PubMed
99.
Ziegler EE, Fomon SJ, Nelson SE, Rebouche CJ, Edwards BB, Rogers RR, Lehman LJ (1990) Cow milk feeding in infancy: further observations on blood loss from the gastrointestinal tract. J Pediatr 116:11–18PubMed
100.
Yasa B, Agaoglu L, Unuvar E (2011) Efficacy, tolerability, and acceptability of iron hydroxide polymaltose complex versus ferrous sulfate: a randomized trial in pediatric patients with iron deficiency anemia. Int J Pediatr 2011:524520PubMedPubMedCentral
101.
Geisser P (2007) Safety and efficacy of iron(III)-hydroxide polymaltose complex. Arzneimittel-Forschung (Drug Research) 57:439–452
102.
Powers JM, Buchanan GR, Adix L, Zhang S, Gao A, McCavit TL (2017) Effect of low-dose ferrous sulfate vs iron polysaccharide complex on hemoglobin concentration in young children with nutritional iron-deficiency anemia: a randomized clinical trial. JAMA 317:2297–2304PubMedPubMedCentral
103.
Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, Melse-Boonstra A, Brittenham G, Swinkels DW, Zimmermann MB (2015) Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 126:1981–1989PubMed
104.
Stoffel NU, Cercamondi CI, Brittenham G, Zeder C, Geurts-Moespot AJ, Swinkels DW, Moretti D, Zimmermann MB (2017) Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol 4:e524–e533PubMed
105.
Stoffel NU, Zeder C, Brittenham GM, Moretti D, Zimmermann MB (2019) Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica:haematol 2019:220830
106.
Litton E, Xiao J, Ho KM (2013) Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ 347:f4822PubMedPubMedCentral
107.
Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J (2004) On the relative safety of parenteral iron formulations. Nephrol Dial Transplant 19:1571–1575PubMed
108.
Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J (2006) Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 21:378–382PubMed
109.
Ng O, Keeler BD, Mishra A, Simpson JA, Neal K, Al-Hassi HO, Brookes MJ, Acheson AG (2019) Iron therapy for preoperative anaemia. Cochrane Database Syst Rev 12:CD011588PubMed
110.
Harris RE, Garrick V, Curtis L, Russell RK (2018) Skin staining due to intravenous iron extravasation in a teenager with Crohn’s disease. Arch Dis Child archdischild-2018-316405
111.
Kalantar-Zadeh K, Regidor DL, McAllister CJ, Michael B, Warnock DG (2005) Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol 16:3070–3080PubMed
112.
Feldman HI, Joffe M, Robinson B, Knauss J, Cizman B, Guo W, Franklin-Becker E, Faich G (2004) Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol 15:1623–1632PubMed
113.
Hoen B, Paul-Dauphin A, Kessler M (2002) Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients. Clin Nephrol 57:457–461PubMed
114.
Wuillemin WA, Krähenbühl S (2010) Hohe Ferritinwerte nach Eiseninfusion - gefährlich? Swiss Med Forum 10:844–846
115.
Mantadakis E (2016) Advances in pediatric intravenous iron therapy. Pediatr Blood Cancer 63:11–16PubMed
116.
Powers JM, McCavit TL, Buchanan GR (2015) Management of iron deficiency anemia: a survey of pediatric hematology/oncology specialists. Pediatr Blood Cancer 62:842–846PubMedPubMedCentral
117.
Boucher AA, Pfeiffer A, Bedel A, Young J, McGann PT (2018) Utilization trends and safety of intravenous iron replacement in pediatric specialty care: a large retrospective cohort study. Pediatr Blood Cancer 65:e26995PubMed
118.
Dortschy R, Schaffrath Rosario A, Scheidt-Nave C, Thamm M, Gutsche J, Markert A (2009) Bevölkerungsbezogene Verteilungswerte ausgewählter Laborparameter aus der Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland (KiGGS). Gesundheitsberichterstattung des Bundes, Robert-Koch-Institut, Berlin
119.
Kurth B-M (2007) Der Kinder- und Jugendgesundheitssurvey (KiGGS): Ein Überblick über Planung, Durchführung und Ergebnisse unter Berücksichtigung von Aspekten eines Qualitätsmanagements. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 50:533–546
120.
Rampton D, Folkersen J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, Patni S, Szebeni J, Weiss G (2014) Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica 99:1671–1676PubMedPubMedCentral
121.
Powers JM, O'Brien SH (2019) How I approach iron deficiency with and without anemia. Pediatr Blood Cancer 66:e27544PubMed
122.
Stein RE, Plantz K, Maxwell EC, Mamula P, Baldassano RN (2018) Intravenous iron sucrose for treatment of iron deficiency anemia in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 66:e51–e55PubMed
123.
Carvalho FSG, de Medeiros IA, Antunes H (2017) Prevalence of iron deficiency anemia and iron deficiency in a pediatric population with inflammatory bowel disease. Scand J Gastroenterol 52:1099–1103PubMed
124.
Danko I (2016) Response of iron deficiency anemia to intravenous iron sucrose in pediatric inflammatory bowel disease. J Pediatr Pharmacol Therap 21:162–168
125.
Danko I, Weidkamp M (2016) Correction of iron deficiency anemia with intravenous iron sucrose in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 63:e107–e111PubMed
126.
Valerio de Azevedo S, Maltez C, Lopes AI (2017) Pediatric Crohn’s disease, iron deficiency anemia and intravenous iron treatment: a follow-up study. Scand J Gastroenterol 52:29–33PubMed
127.
Carman N, Muir R, Lewindon P (2019) Ferric carboxymaltose in the treatment of iron deficiency in pediatric inflammatory bowel disease. Transl Pediatr 8:28–34PubMedPubMedCentral
128.
Papadopoulos M, Patel D, Korologou-Linden R, Goto E, Soondrum K, Fell JME, Epstein J (2018) Safety and efficacy of parenteral iron in children with inflammatory bowel disease. Br J Clin Pharmacol 84:694–699PubMedPubMedCentral
129.
Kaskel FJ (2006) Safety and efficacy of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients. Nat Clin Pract Nephrol 2:244–245PubMed
130.
Leijn E, Monnens LA, Cornelissen EA (2004) Intravenous iron supplementation in children on hemodialysis. J Nephrol 17:423–426PubMed
131.
Ratcliffe LE, Thomas W, Glen J, Padhi S, Pordes BA, Wonderling D, Connell R, Stephens S, Mikhail AI, Fogarty DG, Cooper JK, Dring B, Devonald MA, Brown C, Thomas ME (2016) Diagnosis and management of iron deficiency in CKD: a summary of the NICE guideline recommendations and their rationale. Am J Kidney Dis 67:548–558PubMed
132.
Warady BA, Kausz A, Lerner G, Brewer ED, Chadha V, Brugnara C, Dahl NV, Watkins SL (2004) Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol (Berlin, Germany) 19:655–661
133.
Warady BA, Zobrist RH, Finan E, Ferrlecit Pediatric Study G (2006) Sodium ferric gluconate complex maintenance therapy in children on hemodialysis. Pediatr Nephrol (Berlin, Germany) 21:553–560
134.
Warady BA, Zobrist RH, Wu J, Finan E, Ferrlecit Pediatric Study G (2005) Sodium ferric gluconate complex therapy in anemic children on hemodialysis. Pediatr Nephrol (Berlin, Germany) 20:1320–1327
135.
Morgan HE, Holt RC, Jones CA, Judd BA (2007) Intravenous iron treatment in paediatric chronic kidney disease patients not on erythropoietin. Pediatr Nephrol (Berlin, Germany) 22:1963–1965
136.
Gillespie RS, Symons JM (2005) Sodium ferric gluconate for post-transplant anemia in pediatric and young adult renal transplant recipients. Pediatr Transplant 9:43–46PubMed
137.
Goldstein SL, Morris D, Warady BA (2013) Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial. Am J Kidney Dis 61:588–597PubMed
138.
Yorgin P (2005) Intravenous iron therapy in pediatric transplant recipients: what do we really know? Pediatr Transplant 9:1–3PubMed
139.
Anbu AT, Kemp T, O'Donnell K, Smith PA, Bradbury MG (2005) Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin. Acta Paediatr 94:1738–1741PubMed
140.
DelRosso L, Bruni O (2019) Treatment of pediatric restless legs syndrome. Adv Pharmacol (San Diego, CA) 84:237–253
141.
Grim K, Lee B, Sung AY, Kotagal S (2013) Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose. Sleep Med 14:1100–1104PubMed
142.
Auerbach M (2011) Should intravenous iron be upfront therapy for iron deficiency anemia? Pediatr Blood Cancer 56:511–512PubMed
143.
Mantadakis E (2018) Intravenous iron: safe and underutilized in children. Pediatr Blood Cancer 65:e27016PubMed
144.
Crary SE, Hall K, Buchanan GR (2011) Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. Pediatr Blood Cancer 56:615–619PubMed
145.
Powers JM, Shamoun M, McCavit TL, Adix L, Buchanan GR (2017) Intravenous ferric carboxymaltose in children with iron deficiency anemia who respond poorly to oral iron. J Pediatr 180:212–216PubMed
146.
Mantadakis E, Roganovic J (2017) Safety and efficacy of ferric carboxymaltose in children and adolescents with iron deficiency anemia. J Pediatr 184:241PubMed
147.
Mantadakis E, Tsouvala E, Xanthopoulou V, Chatzimichael A (2016) Intravenous iron sucrose for children with iron deficiency anemia: a single institution study. World J Pediatr 12:109–113PubMed
148.
Pinsk V, Levy J, Moser A, Yerushalmi B, Kapelushnik J (2008) Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. Israel Med Assoc J 10:335–338
149.
Plummer ES, Crary SE, McCavit TL, Buchanan GR (2013) Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. Pediatr Blood Cancer 60:1747–1752PubMed
150.
Tan MLN, Windscheif PM, Thornton G, Gaynor E, Rodrigues A, Howarth L (2017) Retrospective review of effectiveness and safety of intravenous ferric carboxymaltose given to children with iron deficiency anaemia in one UK tertiary centre. Eur J Pediatr 176:1419–1423PubMed
151.
Akarsu S, Taskin E, Yilmaz E, Yilmaz H, Kilic M, Aygun AD (2006) Treatment of iron deficiency anemia with intravenous iron preparations. Acta Haematol 116:51–57PubMed
152.
Clenin G, Cordes M, Huber A, Schumacher YO, Noack P, Scales J, Kriemler S (2015) Iron deficiency in sports - definition, influence on performance and therapy. Swiss Med Wkly 145:w14196PubMed
153.
154.
Akin M, Atay E, Oztekin O, Karadeniz C, Karakus YT, Yilmaz B, Erdogan F (2014) Responsiveness to parenteral iron therapy in children with oral iron-refractory iron-deficiency anemia. Pediatr Hematol Oncol 31:57–61PubMed
155.
Akin M, Sarbay H, Guler S, Balci YI, Polat A (2016) Response to parenteral iron therapy distinguish unexplained refractory iron deficiency anemia from iron-refractory iron deficiency anemia. Int J Lab Hematol 38:167–171PubMed
156.
Giger M, Achermann R (2013) Iron substitution in outpatients in Switzerland: increase of costs associated with intravenous administration. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 107:320–326PubMed
Metadaten
Titel
Diagnosis and management of iron deficiency in children with or without anemia: consensus recommendations of the SPOG Pediatric Hematology Working Group
verfasst von
Veneranda Mattiello
Markus Schmugge
Heinz Hengartner
Nicolas von der Weid
Raffaele Renella
on behalf of the SPOG Pediatric Hematology Working Group
Publikationsdatum
04.02.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 4/2020
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-020-03597-5

Weitere Artikel der Ausgabe 4/2020

European Journal of Pediatrics 4/2020 Zur Ausgabe

Original Article

Do the opinions of pediatricians influence their recommendations on complementary feeding? Preliminary results

Original Article

Team performance during postsurgical patient handovers in paediatric care

Original Article

Postnatal middle cerebral artery Dopplers in growth-restricted neonates

Short Communication

Daily baked egg intake may accelerate the development of tolerance to raw egg in egg-allergic children

Review

Experts’ opinion for improving global adolescent vaccination rates: a call to action

Original Article

Exome sequencing of extreme phenotypes in bronchopulmonary dysplasia

Neu im Fachgebiet Pädiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

16.05.2024 Arterielle Hypertonie in der Pädiatrie Nachrichten

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise